There have not been any declared dividends recently. There are no Oxford Biomedica dividends.
Why are Oxford Biomedica shares falling?
A significant selloff in AstraZeneca shares followed the announcements causing Oxford Biomedica, which manufactures some COVID-19 vaccines for the leading pharma company, to extend their losses. The drug development platform holds significant promise for Oxford Biomedica once COVID-91 sales start declining.
Can I buy shares in Oxford Biomedica?
You can buy or sell Oxford Biomedica plc shares through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account.
What does Oxford Biomedica do?
About Oxford BioMedica Oxford BioMedica is a niche specialist in gene and cell therapy, with a leading position in lentiviral and cell therapy research, development and bioprocessing.
Is Oxford BioMedica a private company?
Type Public company
------- --------------
Website www.oxb.com
Is Oxford BioMedica a good buy?
Oxford Biomedica has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.